Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/1996
12/19/1996CA2787069A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996CA2786782A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996CA2236946A1 Polyether block copolymer micellar compositions for targeting biological agents
12/19/1996CA2224102A1 Bacterial inhibition with an oligosaccharide compound
12/19/1996CA2224015A1 Streptococcal heat shock proteins members of the hsp70 family
12/19/1996CA2223969A1 Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection
12/19/1996CA2223940A1 Macrophage activating factors derived from cloned vitamin d binding protein
12/19/1996CA2223912A1 Methods of combatting infectious diseases using dicationic bis-benzimidazoles
12/19/1996CA2223803A1 Use of bis-1,2,4-triazoles for the manufacture of a medicament for the treatment of cancers
12/19/1996CA2223696A1 Novel derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
12/19/1996CA2223610A1 Nucleic acid respiratory syncytial virus vaccines
12/19/1996CA2223608A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996CA2223591A1 Recombinant fowlpox viruses and uses thereof
12/19/1996CA2223584A1 Crosslinking oligonucleotides
12/19/1996CA2223577A1 Chimeric antibodies for delivery of antigens to selected cells of the immune system
12/19/1996CA2223557A1 Method of improving animal health
12/19/1996CA2223549A1 Capped synthetic rna, analogs, and aptamers
12/19/1996CA2223533A1 Imidazole compounds
12/19/1996CA2223416A1 Recombinant poxvirus-rabies compositions and combination compositions and uses
12/19/1996CA2223299A1 Anti-viral compounds
12/19/1996CA2223268A1 .alpha.-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors
12/19/1996CA2223182A1 Expression system for non-secretor genes
12/19/1996CA2223175A1 Methods of inducing bef-1 transcription factor
12/19/1996CA2223109A1 Use of antisense oligonucleotides to il-6 receptor mrna to inhibit cellular proliferation
12/19/1996CA2223093A1 Anti-viral compounds
12/19/1996CA2223041A1 Immunological combination compositions and methods
12/19/1996CA2223033A1 High affinity human monoclonal antibodies specific for rsv f-protein
12/19/1996CA2222972A1 Reversible cysteine protease inhibitors
12/19/1996CA2222586A1 Thiocationic lipids, pharmaceutical compositions and methods of use thereof
12/19/1996CA2222154A1 Acyclovir derivatives for topical use
12/19/1996CA2221867A1 Small molecule inhibition of rna/ligand binding
12/19/1996CA2221780A1 Anti-fungal d-amino acid histatin-based peptides
12/19/1996CA2221570A1 Neutralizing conformation epitopes of chicken anemia virus
12/19/1996CA2221511A1 Vaccine comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein
12/19/1996CA2221480A1 Mutants of streptococcal toxin a and methods of use
12/19/1996CA2220714A1 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
12/19/1996CA2220006A1 Heterocyclic substituted cyclopentane compounds
12/19/1996CA2218896A1 Bile duct progenitor cells and methods of use
12/18/1996EP0748806A1 POLYMORPHS B AND C OF 1- 2,4-DICHLORO-BETA-[(7-CHLOROBENZO[b]THIEN-3-YL)METHOXY]PHENETYL]IMIDAZOLE MONONITRATE
12/18/1996EP0748631A2 Viral vaccines
12/18/1996EP0748385A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
12/18/1996EP0748383A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences
12/18/1996EP0748376A1 Rna editing enzyme and methods of use thereof
12/18/1996EP0748375A1 Selective virus culture
12/18/1996EP0748335A1 Antibiotic stalobacins
12/18/1996EP0748330A1 L-nucleosides for the treatment of hepatitis b-virus and epstein-bar virus
12/18/1996EP0748329A1 3''-desmethoxy derivatives of erythromycin and azithromycin
12/18/1996EP0748319A1 Process for making an epoxide
12/18/1996EP0748316A1 Pyrimidine acyclonucleoside derivatives
12/18/1996EP0748311A1 Therapeutic benzonitriles
12/18/1996EP0748310A1 Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity
12/18/1996EP0748224A1 Antibacterial agent containing tea extract or active fraction thereof and beta-lactam antibiotic
12/18/1996EP0554284B1 Peptide-based inhibitors of hiv replication
12/18/1996CN1138335A Compounds with growth hormone releasing properties
12/18/1996CN1138326A N-substituted aryl trifluoromethyl imidazoles
12/18/1996CN1138323A Pharmaceutical formulations comprising polythiourea and method of use thereof
12/18/1996CN1137895A Prevention and curing agent for c attenuation living vaccine
12/18/1996CN1033591C Production of pradimicin antibiotics
12/17/1996US5585499 Drug delivery
12/17/1996US5585397 Viricides
12/17/1996US5585379 Skin disorders
12/17/1996US5585365 Antiviral polysaccharide
12/17/1996US5585355 Drug delivery with a bradykinin derivatives
12/17/1996US5585349 Method of treating viral infections
12/17/1996US5585102 Flagella-less borrelia
12/17/1996US5585089 Humanized immunoglobulins
12/17/1996CA1338800C Hepatitis delta and diagnostics and vaccines
12/13/1996CA2178553A1 Marek's disease vaccine
12/12/1996WO1996039629A1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
12/12/1996WO1996039522A1 Human chemokine beta-11 and human chemokine alpha-1
12/12/1996WO1996039499A1 TNF-α RIBOZYMES, TNF-α RIBOZYME BINDING PROTEIN AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-α RIBOZYMES
12/12/1996WO1996039491A1 Recombinant poxvirus - cytomegalovirus compositions and uses
12/12/1996WO1996039411A1 Substituted liposaccharides useful in the treatment and prevention of endotoxemia
12/12/1996WO1996039408A1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO[3,4-c]-1,2,4-TRIAZOLO[4,3-α]PYRIDINES
12/12/1996WO1996039407A1 Quinolizinone type compounds
12/12/1996WO1996039406A1 NOVEL CRYSTAL FORM OF ANHYDROUS 7-([1α, 5α, 6α]-6-AMINO-3-AZABICYCLO[3.1.0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT
12/12/1996WO1996039192A1 Treatment of cholera
12/12/1996WO1996039191A1 Treatment of cholera
12/12/1996WO1996039190A1 Treatment of traveller's diarrhea
12/12/1996WO1996039189A1 Treatment of traveller's diarrhea
12/12/1996WO1996039179A1 Novel recombinant temperature sensitive mutants of influenza
12/12/1996WO1996039177A1 Recombinant poxvirus-calicivirus [rabbit hemorrhagic disease virus (rhdv)] compositions and uses
12/12/1996WO1996039154A1 Oligonucleotides having phosphorothioate linkages of high chiral purity
12/12/1996WO1996039145A1 Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties
12/12/1996WO1996039142A1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
12/12/1996WO1996039123A1 Oral veterinary fluoroquinolone antibacterial composition for extended duration of therapy and method of treating
12/12/1996WO1996034010A3 Inhibitors of farnesyl-protein transferase
12/12/1996WO1996033730A3 Chemokine binding protein and methods of use therefor
12/12/1996WO1996033282A3 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
12/12/1996CA2423891A1 Novel recombinant temperature sensitive mutants of influenza
12/12/1996CA2223419A1 Recombinant poxvirus-calicivirus [rabbit hemorrhagic disease virus (rhdv)] compositions and uses
12/12/1996CA2223282A1 Recombinant poxvirus - cytomegalovirus compositions and uses
12/12/1996CA2223103A1 Oligonucleotides having phosphorothioate linkages of high chiral purity
12/12/1996CA2222950A1 Oral veterinary fluoroquinolone antibacterial composition for extended duration of therapy and method of treating
12/12/1996CA2222643A1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
12/12/1996CA2222322A1 Quinolizinone type compounds
12/12/1996CA2222280A1 Human chemokine beta-11 and human chemokine alpha-1
12/12/1996CA2210291A1 Treatment of cholera
12/12/1996CA2210227A1 Treatment of cholera
12/12/1996CA2210202A1 Treatment of traveller's diarrhea
1 ... 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 ... 1798